18th, November, 2010 - New-York, US

Olea Medical is pleased to announce that Dr Lawrence N. Tanenbaum, M.D., FACR has joined its Medical Advisory Board.

Fayçal Djeridane, CEO of Olea Medical, declared: “We are very happy to welcome Dr. Tanenbaum as member of our Medical Advisory Board. Dr. Tanenbaum is a leading clinician, educator, and an outstanding integrator of leading-edge technology and advanced imaging techniques into productive clinical practice.”

Dr. Tanenbaum is an Associate Professor of Radiology and the Director of MRI, CT and Outpatient / Advanced Imaging Development at Mount Sinai School of Medicine in New York stated: “I am enthused to become a part of the team of Advisors that contribute to the continuing development of Olea's advanced visualization products for neurological MRI and CT ».

Focusing on the processing of perfusion imaging, Olea Medical offers efficient software solutions - PerfScape™ & NeuroScape™ - to make the evaluation of acute stroke and brain tumor easier.

Press contact : Marine Pagni

marine.pagni@olea-medical.com - +33 (0)4 42 71 24 20

Close

29th, October 2010 - Badalona, SPAIN

THE UNIVERSITY HOSPITAL GERMANS TRIAS I PUJOL (BADALONA, SPAIN) AND THE INSTITUTE OF DIAGNOSTIC IMAGING (IDI) ANNOUNCE THE ACQUISITION OF THE INNOVATIVE MR PERFUSION POST-PROCESSING STROKE DIAGNOSIS SUITE – PERFSCAPE™ & NEUROSCAPE™ - DESIGNED BY OLEA MEDICAL TO MAKE MORE ACCURATE AND FASTER DIAGNOSIS.

As the stroke reference center in Catalonia and the second user of PerfScape™ & NeuroScape™ in Spain, Germans Trias i Pujol and the IDI (Institute of Diagnostic Imaging, Dra. Sira Domènech, in charge of the Neuroimaging Departement) confirm their leadership in the neuroscience field by using the most advanced imaging technique.

FDA-cleared and CE marked, PerfScape™ & NeuroScape™ instantly display all perfusion and diffusion maps, and quantify infarcted and penumbral tissues in acute stroke patients with nominal input from users.

PerfScape™ & NeuroScape™ offer a fast and effective solution to stroke centers that wish to rely on MRI to evaluate and triage acute stroke patients.

Pr. Antoni Dávalos, head of the Department of Neurosciences at the Hospital Universitari Germans Trias i Pujol stated, "Olea Medical develops fast, accurate and easy tools that allow physicians to obtain never observed, up to now, results in the stroke post-processing field.”

Press contact : Marine Pagni

marine.pagni@olea-medical.com - +33 (0)4 42 71 24 20

Close

13th, July 2010 -

University Hospitals Case Medical Center (UHCMC) and Olea Medical USA partner to implement the innovative MR perfusion processing software - PerfScape™ & NeuroScape™ - to evaluate acute stroke and triage patients.

As a leader in neurocritical care and stroke, UHCMC uses the most advanced imaging technics, including PerfScape™ & NeuroScape™.

About Olea Medical Software solutions

An FDA-cleared MR perfusion software package, PerfScape™ & NeuroScape™ instantly displays all perfusion and diffusion maps, and quantifies infarcted and penumbral tissues in acute stroke patients with nominal input from the user.

PerfScape™ & NeuroScape™ offers a fast and effective solution to stroke centers that wish to rely on MRI to evaluate and triage acute stroke patients.

Press contact : Marine Pagni

marine.pagni@olea-medical.com - +33 (0)4 42 71 24 20

Close

28th, May 2010 - Barcelona, SPAIN

Olea Medical’s stroke diagnosis suite surpasses its main competitors in a comparative study conducted at the Center for Stroke Research Berlin at Charité-university hospital that aims to evaluate four major post-processing software packages used for perfusion MRI assessment. The investigation, led by Prof. Fiebach and the Stroke MRI group, reveals considerable discrepancies between the different applications and highlights the superior performances of PerfScape™ & NeuroScape™.
The different software solutions are rated on the grounds of accuracy, speed, and automated AIF selection among others. Based on these criteria, Olea Medical’s stroke suite outperforms its competitors on the following criteria: calculation time, mismatch evaluation, artefacts, and user friendliness.

These results stand in the line of a series of scientific studies, including PerfScape™ & NeuroScape™ conducted by major stroke research centers worldwide (i.e. NIH/NINDS).

About Olea Medical Software solutions

FDA-cleared and CE marked,PerfScape™ & NeuroScape™ instantly display all perfusion and diffusion maps, and quantify infarcted and penumbral tissues in acute stroke patients with nominal input from users.

PerfScape™ & NeuroScape™ offer a fast and effective solution to stroke centers that wish to rely on MRI to evaluate and triage acute stroke patients.

Press contact : Marine Pagni

marine.pagni@olea-medical.com - +33 (0)4 42 71 24 20

Close

25th, May 2010 - Barcelona, SPAIN

The University Hospital of Vall d'Hebron (Barcelona, Spain) and Olea Medical partner to implement the innovative MR perfusion post-processing software – PerfScape™ & NeuroScape™ designed to make more accurate and faster diagnosis.

As reference center and first user of PerfScape™ & NeuroScape™ in Spain, Vall d'Hebron confirms its leadership in the neurosciences field by using the most advanced imaging technique.
FDA-cleared and CE marked, PerfScape™ & NeuroScape™ instantly display all perfusion and diffusion maps, and quantify infarcted and penumbral tissues in acute stroke patients with nominal input from users.

PerfScape™ & NeuroScape™ offer a fast and effective solution to stroke centers that wish to rely on MRI to evaluate and triage acute stroke patients.

Prof. Rovira stated, "the suite of software brought by Olea Medical as well as the new solutions that will be available in the near future represent a tremendous asset for a radiology department".

Press contact : Marine Pagni

marine.pagni@olea-medical.com - +33 (0)4 42 71 24 20

Close

Olea Medical USA has provided financial support to Massachusetts General Hospital's Princeton Conference that will take place April 22-25, 2010 in Boston, Massachusetts. This educational program is a premier academic conference in the field of cerebrovascular disease.

Mass General and the Director of the Princeton Conference decided upon the topics for the program based on their strategic impact on understanding the underlying mechanisms of stroke and the development of innovative treatments. The planned sessions will include stroke prevention and recovery, neuroimaging, interventional approaches, intracerebral hemorrhage, neuroprotective strategies, and thrombolytic therapies.

Olea Medical USA provides innovative imaging applications that help physicians make fast and accurate diagnosis of acute stroke.

Press contact : Marine Pagni

marine.pagni@olea-medical.com - +33 (0)4 42 71 24 20

Close

Olea Medical, the NIH/NINDS and the Stroke Center of La Timone University Hospital in France collaborate to define PWI/DWI thresholds to better assess salvageable penumbral areas.

- La Ciotat, France, November 6th, 2009 – Olea Medical, the NIH National Institute of Neurological Disorders and Stroke (NINDS) Section on Stroke Diagnostics and Therapeutics, and the Stroke Center of La Timone University Hospital in France will collaborate to define efficient thresholds of diffusion and perfusion maps with a view to accurately assessing salvageable penumbral areas.

Olea Medical (www.olea-medical.com) provides innovative imaging software solutions to help stroke physicians make fast and accurate diagnosis of acute stroke. NINDS (www.ninds.nih.gov) is the United States’ primary supporter of biomedical research on the brain and nervous system. As part of this collaboration, NINDS scientists, led by Dr. Steven Warach, will be using PerfScape™ and NeuroScape™, Olea Medical’s FDA-cleared software, in a prospective study comparing mismatch calculations produced with the software of Olea Medical versus qualitative evaluations of mismatch using MRI scanner provided images only.In a proof of concept study, Warach and colleagues reported that processing acute MRI studies is feasible using the Olea software.

About Olea Medical

Olea Medical designs and markets innovative acute stroke imaging applications that significantly improve the diagnosis process of acute stroke. Olea Medical aims to become the leader in providing safe & accurate medical imaging software allowing physicians to make faster and improved diagnosis, thus saving lives. PerfScape™ allows computing instantaneously perfusion maps from raw MRI data with unparalleled quality and not machine-dependent as it works on all MR scanners used in your hospital (Siemens, Philips, Toshiba, GE...). NeuroScape™ makes an instant multiparametric analysis of all series of images given by the MR scanners, and enables physicians to calculate the lesion volume, hypoperfused volume, and the mismatch diffusion/perfusion ratio. For more information about Olea Medical, please visit www.olea-medical.com

About the NIH – NINDS

The National Institute of Neurological Disorders and Stroke (NINDS) conducts and supports research on brain and nervous system disorders. Created by the U.S. Congress in 1950, NINDS is one of the more than two dozen research institutes and centers that comprise the National Institutes of Health (NIH). The NIH, located in Bethesda, Maryland, is an agency of the Public Health Service within the U.S. Department of Health and Human Services. NINDS has occupied a central position in the world of neuroscience for more than 50 years. The mission of NINDS is to reduce the burden of neurological disease - a burden borne by every age group, by every segment of society, by people all over the world. For more information about the mission and activities of NINDS, see the NINDS Overview, please visit : www.ninds.nih.gov

Press contact : Marine Pagni

marine.pagni@olea-medical.com - +33 (0)4 42 71 24 20

Close